Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Metastatic Colorectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01972490
What this trial is testing

Avastin in Combination With Chemotherapy for RAS Mutant Unresectable Colorectal Liver-limited Metastases

Who this might be right for
Colorectal Neoplasms
Xu jianmin 241
Testing effectiveness (Phase 2)UnknownNCT06148402
What this trial is testing

Fruquintinib Plus Camrelizumab and Capecitabine as Salvage Therapy After Progression on FOLFOXIRI-based First-line Treatment in Patients With Unresectable/Metastatic Colorectal Cancer

Who this might be right for
Unresectable/Metastatic Colorectal Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 30
Testing effectiveness (Phase 2)WithdrawnNCT07323576
What this trial is testing

Evaluate the Efficacy and Safety of Inavolisib When Administered in Combination With Bevacizumab and FOLFOX or FOLFIRI as First Line Therapy in Participants With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche
Testing effectiveness (Phase 2)Study completedNCT00625651
What this trial is testing

Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CancerColon CancerColorectal Cancer+1 more
Amgen 202
Not applicableWithdrawnNCT01631539
What this trial is testing

Chemoembolisation With CPT11 Loaded DC Bead With Cetuximab and 5FU/LV in First Line in Patients With KRAS Wildtype mCRC

Who this might be right for
Liver MetastasesColorectal Cancer
Universitaire Ziekenhuizen KU Leuven
Testing effectiveness (Phase 2)Ended earlyNCT00845039
What this trial is testing

Irinotecan and Cetuximab With or Without IMC-A12 for Treatment of Participants With Colon or Rectum Cancer Who Got Worse After Their First Treatment With Oxaliplatin and Bevacizumab

Who this might be right for
Colon CancerRectal Cancer
Eli Lilly and Company 4
Not applicableStudy completedNCT01696695
What this trial is testing

An Observational Study of First-Line Capecitabine Based Chemotherapy in Participants With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 882
Testing effectiveness (Phase 2)Study completedNCT02705300
What this trial is testing

Side Effects to FOLFOXIRI + Tocotrienol/Placebo as First Line Treatment of Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Vejle Hospital 70
Testing effectiveness (Phase 2)WithdrawnNCT00388700
What this trial is testing

A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Galectin Therapeutics Inc.
Testing effectiveness (Phase 2)Study completedNCT00118755
What this trial is testing

Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 435
Not applicableStudy completedNCT01319877
What this trial is testing

An Observational Study of Bevacizumab in Combination With 5-FU-Based Chemotherapy in Chinese Participants With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 609
Testing effectiveness (Phase 2)UnknownNCT02717923
What this trial is testing

A Single Arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Maintenance Treatment With Capecitabine Plus Cetuximab in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Huazhong University of Science and Technology 50
Testing effectiveness (Phase 2)UnknownNCT05839470
What this trial is testing

Cadonilimab Plus FOLFOXIRI and Bevacizumab as First Line Therapy for Metastatic MSS Colorectal Cancer

Who this might be right for
Colorectal Cancer
Fujian Cancer Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00556413
What this trial is testing

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 42
Large-scale testing (Phase 3)UnknownNCT03389659
What this trial is testing

XELOX/mFOLFOX Plus Vitamin D3 vs. XELOX/mFOLFOX as Firstline Chemotherapy in mCRC

Who this might be right for
Vitamin D3
Tianjin Medical University Cancer Institute and Hospital 750
Not applicableUnknownNCT01943786
What this trial is testing

RAS Switch in Patients With Metastatic RAS Native Colorectal Tumors Treated With 1st Line FOLFIRI-Cetuximab

Who this might be right for
Colorectal Cancer Metastatic
Sofia Perea, Director Clinical Trials Unit. 40
Testing effectiveness (Phase 2)Looking for participantsNCT06907342
What this trial is testing

Testing a Functional Precision Medicine Approach to Select Chemotherapy for Metastatic Colorectal Cancer (COSENSE-1)

Who this might be right for
Tumor, ColorectalOrganoidsTumoroid+3 more
St. Olavs Hospital 148
Testing effectiveness (Phase 2)Study completedNCT01875380
What this trial is testing

Regorafenib in Frail and/or Unfit for Chemotherapy Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsMetastatic Disease
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 46
Large-scale testing (Phase 3)Ended earlyNCT00499369
What this trial is testing

Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IVA Colon Cancer+3 more
National Cancer Institute (NCI) 72
Testing effectiveness (Phase 2)Ended earlyNCT01765582
What this trial is testing

Sequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Hoffmann-La Roche 280
Next Page